Biomarker ID | 257 |
PMID | 18347174 |
Year | 2008 |
Biomarker | ERG |
Biomarker Basis | Expression Based |
Biomolecule | mRNA |
Source | Tissue |
Subjects | Humans |
Regulation | Upregulated in PCa (≥2 fold) |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways Include:-Genes targeted by miRNAs in adipocytes WP1992,VEGFA-VEGFR2 Signaling Pathway WP3888 |
Experiment | Prostate Cancer Vs Nonneoplastic Sample |
Type of Biomarker | Diagnostic |
Cohort | Previously acquired gene expression profiles were analyzed from 102 tumor and nonneoplastic LCM-derived samples |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p<0.05 |
Method Used | Microarrays |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | ERG |